Novel production process for the Serratia nuclease enzyme
c-LEcta has established a novel production process for the Serratia nuclease enzyme from Serratia marcescens. This new process is based on a proprietary Bacillus strain from c-LEcta. With respect to safety this strain is clearly superior to traditional strains. Serratia nuclease is employed during the production of biopharmaceuticals and vaccines to efficiently remove all nucleic acids, which helps in reducing the viscosity of the biological materials and improving the manufacturing process. The Serratia nuclease product from c-LEcta combines all the known advantages of the established enzyme with a new and safe production process. The production of the Serratia nuclease is a further example of the competence and innovation of c-LEcta in the areas of strain and process development.